from Dr Mercola

Pfizer paid undisclosed sums to groups advocating for vaccine mandates, bypassing the appearance of a conflict of interest. But who were these groups, and how did Pfizer’s power games influence public policy?

STORY AT-A-GLANCE

• In 2022, Pfizer became the first drug company in history to break $100 billion in annual sales. That year, Pfizer spent $2.8 billion on ads, an increase of $800 million from 2021
• But Pfizer’s success isn’t due to direct ads. It’s because a) the U.S. government spent $1 billion of taxpayers’ money to promote the experimental covid jab, and b) Pfizer paid millions to consumer, medical and civil rights groups that lobbied for covid jab mandates on Pfizer’s behalf
• Special interest groups paid by Pfizer to push for covid jab mandates and coercive vaccine policies include the Chicago Urban league (which argued that the jab mandate would benefit the Black community), the National Consumers League, the Immunization Partnership, the Advertising Council and a long list of universities and cancer, liver diseases, cardiology, rheumatology and medical science organizations
• April 19, 2023, the U.S. Centers for Disease Control and Prevention revised its covid jab guidance. The original monovalent mRNA shots are no longer recommended for use in the U.S. Instead, the CDC recommends people 6 years old and older get an updated bivalent mRNA covid shot, even if they’ve not completed the monovalent series
• While the World Health Organization seems to be backing off from endless covid boosters for all, there’s clear evidence that mRNA gene therapy is here to stay. mRNA “vaccines” are in the works for influenza, respiratory syncytial virus (RSV), shingles, genital herpes and cancer, just to name a few

Thanks to its experimental gene therapy injection for covid-19, in 2022, Pfizer became the first drug company in history to break $100 billion in annual sales.¹ But its mere existence didn’t ensure Pfizer’s success.

No, massive media promotion and government-backed coercion did that. Not only did the U.S. government pay news media a staggering $1 billion to promote and build public confidence in the experimental jab, but as reported by Russell Brand in this video, Pfizer also poured billions of dollars into advertising.

In 2022, Pfizer spent $2.8 billion on ads, an increase of $800 million from 2021. On top of that, Pfizer also paid big bucks to consumer, medical and civil rights groups to lobby for COVID jab mandates. Journalist Lee Fang reviewed this in his interview with Brand (video above) and in an April 24, 2023, Substack article.² As Fang told Brand:

“San Francisco … in September of 2021, enacted a very kind of strong mandate with no exemption for prior immunity … or … natural immunity. Pfizer was not playing a visible role here. They didn’t comment on any of the articles. They weren’t really talking to the press.

You saw consumer groups, civil rights groups, patient groups, doctors groups, public health organizations, all saying these mandates are necessary, even though there wasn’t a lot of scientific evidence to support the basis that we needed these mandates. [The shots] were sold to us with the claim that they would stop transmission of the virus.

You had this coalition of community groups saying we need the mandate. Well, I’m taking a look at new disclosures that show that many of those organizations, these third party organizations … were taking funds from Pfizer while lobbying for these controversial policies …

[The drug industry doesn’t] have to disclose how much they’re spending on television, how much they’re spending on TikTok ads, how much they’re giving to these front groups, or these doctors groups, or these public health groups that set the nature of the debate.

They appear in the news media, they create events, and they create a discourse that looks authentic, that looks organic, but it benefits the bottom line of their benefactors — companies like Pfizer.

And the vaccine debate … has shaped our lives in the last three years of the pandemic. But it’s also not that unique in the sense that every major pharmaceutical company in the United States engages in these practices. They pressure regulators, they spend so much money on direct-to-consumer advertising.

And really, they kind of just dominate the entire public policy debate. So we can talk about a lot of other special interest groups, but Pharma is unique [in terms of] the raw amounts of money they spend to control the entire public sector, on regulatory policy, on everything, in terms of how it affects medicine …”

Dozens of Pfizer-paid Health Care Organizations Called for Mandates

Special interest groups paid by Pfizer³ to push for covid jab mandates and coercive vaccine policies include the Chicago Urban league (which argued that the jab mandate would benefit the Black community), the National Consumers League, the Immunization Partnership, the Advertising Council and a long list of universities and cancer, liver diseases, cardiology, rheumatology and medical science organizations.

Pfizer didn’t have to take a prominent stand to argue for vaccine mandates, which would have been an obvious conflict of interest. They paid others to push the mandates for them.

Each of these organizations received anywhere from several thousand to hundreds of thousands of dollars from Pfizer in 2021 alone. Is it any wonder, then, that more than 50 major health care organizations called for vaccine mandates that year, including for their own workers?⁴ I don’t think so.

Pfizer didn’t have to take a prominent stand to argue for vaccine mandates, which would have been an obvious conflict of interest. They paid others to push the mandates for them. Of course, Pfizer and the U.S. government are also in partnership, as acknowledged on Pfizer’s Political Partnership page.⁵

New covid jab guidelines issued

In related news, April 19, 2023, the U.S. Centers for Disease Control and Prevention revised its covid jab guidance.^6,7,8 The original monovalent mRNA shots are no longer recommended for use in the U.S. Instead, the CDC recommends people 6 years old and older get an updated bivalent mRNA covid shot, even if they’ve not completed the monovalent series.

The update comes on the heels of the World Health Organization’s Strategic Advisory Group of Experts on Immunization’s (SAGE) meeting in late March 2023, during which they decided that continued injection efforts should be focused on getting boosters into the arms of the elderly and those with underlying conditions, including young children, young adults and pregnant women with diabetes, heart disease or immunocompromising conditions. As reported by the WHO:⁹

“For the high priority group, SAGE recommends an additional booster of either 6 or 12 months after the last dose, with the timeframe depending on factors such as age and immunocompromising conditions.

All the COVID-19 vaccine recommendations are time-limited, applying for the current epidemiological scenario only, and so the additional booster recommendations should not be seen as for continued annual COVID-19 vaccine boosters …

Separate to the roadmap, SAGE also updated their recommendations on bivalent COVID-19 vaccines, now recommending that countries can consider using BA.5 bivalent mRNA vaccine for the primary series.”